[{"edinetCode":"E27208","endDate":"2017\/12\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":23.0,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":2522500.0,"sharesOwendPercent":0.2838,"outstandingShares":null,"numberOfSubsidiary":1.0,"bps":218.72,"equityRatio":0.911,"cashAndCashEquivalents":1126794000.0,"assets":2133117000.0,"currentAssets":1836365000.0,"fixedAsset":296751000.0,"tangibleFixedAssets":220133000.0,"intangibleFixedAssets":632000.0,"investmentAndOtherAssets":75985000.0,"liabilities":99055000.0,"currentLiabilities":88651000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":10403000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":2034061000.0,"capitalStock":1945177000.0,"capital":5298539000.0,"capitalSurplus":4867739000.0,"accumulatedEarnings":-8221100000.0,"treasuryStock":null,"valuationAndConversionAdjustments":-857000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":198212000.0,"costOfSales":7038000.0,"grossProfit":191174000.0,"sgaExpenses":1174587000.0,"salaryAndBenefit":55250000.0,"depreciationAndSGA":3076000.0,"RDExpenses":888118000.0,"operatingIncome":-983412000.0,"nonOperatingIncome":5104000.0,"nonOperatingExpenses":10552000.0,"interestExpense":null,"ordinaryProfit":-988860000.0,"extraordinaryGain":143116000.0,"extraordinaryLoss":34300000.0,"incomeBeforeTax":-880044000.0,"incomeTaxes":4342000.0,"netIncome":-884387000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-884387000.0,"comprehensiveIncome":-881645000.0,"eps":-103.16,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":-854320000.0,"depreciationAndCashflowFromOperatingActivities":59171000.0,"cashFlowFromInvestingActivities":-661486000.0,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":-1513142000.0,"列1":"asr","submitDate":"2018\/3\/28","stockCode":4586,"accountingYear":"第16期（自? 平成29年１月１日? 至? 平成29年12月31日）","accountingYearStart":"2017\/1\/1","accountingYearEnd":"2017\/12\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E27208","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":5101,"settlementDate":"2022\/12\/31","submitterName":"株式会社メドレックス","submitterNameEnglish":null,"submitterNameKana":"カブシキガイシャメドレックス","location":"東かがわ市西山４３１番地７","industory":"医薬品","corporateNumber":3470000000000.0},{"edinetCode":"E27208","endDate":"2018\/12\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":28.0,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":2118600.0,"sharesOwendPercent":0.2074,"outstandingShares":null,"numberOfSubsidiary":1.0,"bps":203.19,"equityRatio":0.898,"cashAndCashEquivalents":1796871000.0,"assets":2311475000.0,"currentAssets":1937946000.0,"fixedAsset":373528000.0,"tangibleFixedAssets":295714000.0,"intangibleFixedAssets":73000.0,"investmentAndOtherAssets":77740000.0,"liabilities":180870000.0,"currentLiabilities":170330000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":10540000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":2130605000.0,"capitalStock":2076017000.0,"capital":5997802000.0,"capitalSurplus":5567002000.0,"accumulatedEarnings":-9488786000.0,"treasuryStock":null,"valuationAndConversionAdjustments":-647000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":8397000.0,"costOfSales":2443000.0,"grossProfit":5953000.0,"sgaExpenses":1279324000.0,"salaryAndBenefit":46097000.0,"depreciationAndSGA":3020000.0,"RDExpenses":980517000.0,"operatingIncome":-1273370000.0,"nonOperatingIncome":5564000.0,"nonOperatingExpenses":17236000.0,"interestExpense":null,"ordinaryProfit":-1285042000.0,"extraordinaryGain":19815000.0,"extraordinaryLoss":null,"incomeBeforeTax":-1265227000.0,"incomeTaxes":2458000.0,"netIncome":-1267686000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-1267686000.0,"comprehensiveIncome":-1267476000.0,"eps":-126.77,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":-1260847000.0,"depreciationAndCashflowFromOperatingActivities":39911000.0,"cashFlowFromInvestingActivities":568539000.0,"cashFlowFromFinancialActivities":1362170000.0,"changesInCashAndCashEquivalents":670076000.0,"列1":"asr","submitDate":"2019\/3\/27","stockCode":4586,"accountingYear":"第17期（自? 2018年１月１日? 至? 2018年12月31日）","accountingYearStart":"2018\/1\/1","accountingYearEnd":"2018\/12\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E27208","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":5101,"settlementDate":"2022\/12\/31","submitterName":"株式会社メドレックス","submitterNameEnglish":null,"submitterNameKana":"カブシキガイシャメドレックス","location":"東かがわ市西山４３１番地７","industory":"医薬品","corporateNumber":3470000000000.0},{"edinetCode":"E27208","endDate":"2019\/3\/31","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.901,"cashAndCashEquivalents":null,"assets":2233783000.0,"currentAssets":1728336000.0,"fixedAsset":505446000.0,"tangibleFixedAssets":428319000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":77126000.0,"liabilities":168477000.0,"currentLiabilities":157902000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":10575000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":2065305000.0,"capitalStock":2014736000.0,"capital":6200742000.0,"capitalSurplus":5769942000.0,"accumulatedEarnings":-9955949000.0,"treasuryStock":null,"valuationAndConversionAdjustments":-1200000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":18689000.0,"costOfSales":3327000.0,"grossProfit":15362000.0,"sgaExpenses":495067000.0,"salaryAndBenefit":12765000.0,"depreciationAndSGA":744000.0,"RDExpenses":420519000.0,"operatingIncome":-479704000.0,"nonOperatingIncome":1748000.0,"nonOperatingExpenses":6723000.0,"interestExpense":null,"ordinaryProfit":-484678000.0,"extraordinaryGain":19578000.0,"extraordinaryLoss":null,"incomeBeforeTax":-465100000.0,"incomeTaxes":2062000.0,"netIncome":-467162000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-467162000.0,"comprehensiveIncome":-467716000.0,"eps":-45.01,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2019\/5\/13","stockCode":4586,"accountingYear":null,"accountingYearStart":"2019\/1\/1","accountingYearEnd":"2019\/12\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E27208","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":5101,"settlementDate":"2022\/12\/31","submitterName":"株式会社メドレックス","submitterNameEnglish":null,"submitterNameKana":"カブシキガイシャメドレックス","location":"東かがわ市西山４３１番地７","industory":"医薬品","corporateNumber":3470000000000.0},{"edinetCode":"E27208","endDate":"2019\/6\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":2877600.0,"sharesOwendPercent":0.2263,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.941,"cashAndCashEquivalents":1874981000.0,"assets":2479213000.0,"currentAssets":1982942000.0,"fixedAsset":496271000.0,"tangibleFixedAssets":419685000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":76585000.0,"liabilities":95686000.0,"currentLiabilities":85075000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":10610000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":2383527000.0,"capitalStock":2333885000.0,"capital":6560666000.0,"capitalSurplus":6129866000.0,"accumulatedEarnings":-10356646000.0,"treasuryStock":null,"valuationAndConversionAdjustments":-1226000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":28880000.0,"costOfSales":3327000.0,"grossProfit":25553000.0,"sgaExpenses":902599000.0,"salaryAndBenefit":24732000.0,"depreciationAndSGA":1464000.0,"RDExpenses":756716000.0,"operatingIncome":-877045000.0,"nonOperatingIncome":2620000.0,"nonOperatingExpenses":10349000.0,"interestExpense":null,"ordinaryProfit":-884775000.0,"extraordinaryGain":19578000.0,"extraordinaryLoss":null,"incomeBeforeTax":-865196000.0,"incomeTaxes":2663000.0,"netIncome":-867859000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-867859000.0,"comprehensiveIncome":-868438000.0,"eps":-77.14,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":-832674000.0,"depreciationAndCashflowFromOperatingActivities":17699000.0,"cashFlowFromInvestingActivities":-214532000.0,"cashFlowFromFinancialActivities":1125727000.0,"changesInCashAndCashEquivalents":78109000.0,"列1":"q2r","submitDate":"2019\/8\/13","stockCode":4586,"accountingYear":null,"accountingYearStart":"2019\/1\/1","accountingYearEnd":"2019\/12\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E27208","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":5101,"settlementDate":"2022\/12\/31","submitterName":"株式会社メドレックス","submitterNameEnglish":null,"submitterNameKana":"カブシキガイシャメドレックス","location":"東かがわ市西山４３１番地７","industory":"医薬品","corporateNumber":3470000000000.0},{"edinetCode":"E27208","endDate":"2019\/9\/30","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.91,"cashAndCashEquivalents":null,"assets":2202658000.0,"currentAssets":1677918000.0,"fixedAsset":524739000.0,"tangibleFixedAssets":448914000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":75824000.0,"liabilities":150452000.0,"currentLiabilities":139806000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":10645000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":2052205000.0,"capitalStock":2005263000.0,"capital":6560666000.0,"capitalSurplus":6129866000.0,"accumulatedEarnings":-10685269000.0,"treasuryStock":null,"valuationAndConversionAdjustments":-1669000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":168228000.0,"costOfSales":5251000.0,"grossProfit":162977000.0,"sgaExpenses":1372479000.0,"salaryAndBenefit":35832000.0,"depreciationAndSGA":2195000.0,"RDExpenses":1161642000.0,"operatingIncome":-1209501000.0,"nonOperatingIncome":5626000.0,"nonOperatingExpenses":11172000.0,"interestExpense":null,"ordinaryProfit":-1215047000.0,"extraordinaryGain":21834000.0,"extraordinaryLoss":null,"incomeBeforeTax":-1193212000.0,"incomeTaxes":3269000.0,"netIncome":-1196482000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-1196482000.0,"comprehensiveIncome":-1197504000.0,"eps":-101.88,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2019\/11\/13","stockCode":4586,"accountingYear":null,"accountingYearStart":"2019\/1\/1","accountingYearEnd":"2019\/12\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E27208","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":5101,"settlementDate":"2022\/12\/31","submitterName":"株式会社メドレックス","submitterNameEnglish":null,"submitterNameKana":"カブシキガイシャメドレックス","location":"東かがわ市西山４３１番地７","industory":"医薬品","corporateNumber":3470000000000.0},{"edinetCode":"E27208","endDate":"2019\/12\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":26.0,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":2448308.0,"sharesOwendPercent":0.1785,"outstandingShares":null,"numberOfSubsidiary":1.0,"bps":136.46,"equityRatio":0.914,"cashAndCashEquivalents":1410791000.0,"assets":2047663000.0,"currentAssets":1501027000.0,"fixedAsset":546635000.0,"tangibleFixedAssets":471464000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":75170000.0,"liabilities":126834000.0,"currentLiabilities":116154000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":10680000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":1920828000.0,"capitalStock":1873411000.0,"capital":6704656000.0,"capitalSurplus":6273856000.0,"accumulatedEarnings":-11105101000.0,"treasuryStock":null,"valuationAndConversionAdjustments":-2011000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":169860000.0,"costOfSales":5251000.0,"grossProfit":164609000.0,"sgaExpenses":1792584000.0,"salaryAndBenefit":46213000.0,"depreciationAndSGA":2941000.0,"RDExpenses":1512199000.0,"operatingIncome":-1627975000.0,"nonOperatingIncome":12837000.0,"nonOperatingExpenses":18127000.0,"interestExpense":null,"ordinaryProfit":-1633265000.0,"extraordinaryGain":21834000.0,"extraordinaryLoss":null,"incomeBeforeTax":-1611430000.0,"incomeTaxes":4883000.0,"netIncome":-1616314000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-1616314000.0,"comprehensiveIncome":-1617679000.0,"eps":-134.32,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":-1546956000.0,"depreciationAndCashflowFromOperatingActivities":40176000.0,"cashFlowFromInvestingActivities":-252341000.0,"cashFlowFromFinancialActivities":1414524000.0,"changesInCashAndCashEquivalents":-386079000.0,"列1":"asr","submitDate":"2020\/3\/30","stockCode":4586,"accountingYear":"第18期（自? 2019年１月１日? 至? 2019年12月31日）","accountingYearStart":"2019\/1\/1","accountingYearEnd":"2019\/12\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E27208","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":5101,"settlementDate":"2022\/12\/31","submitterName":"株式会社メドレックス","submitterNameEnglish":null,"submitterNameKana":"カブシキガイシャメドレックス","location":"東かがわ市西山４３１番地７","industory":"医薬品","corporateNumber":3470000000000.0},{"edinetCode":"E27208","endDate":"2020\/3\/31","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.941,"cashAndCashEquivalents":null,"assets":2044105000.0,"currentAssets":1504789000.0,"fixedAsset":539315000.0,"tangibleFixedAssets":464253000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":75062000.0,"liabilities":75470000.0,"currentLiabilities":64754000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":10716000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":1968634000.0,"capitalStock":1924411000.0,"capital":6881241000.0,"capitalSurplus":6450441000.0,"accumulatedEarnings":-11407270000.0,"treasuryStock":null,"valuationAndConversionAdjustments":-1597000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":null,"costOfSales":null,"grossProfit":null,"sgaExpenses":305874000.0,"salaryAndBenefit":9944000.0,"depreciationAndSGA":794000.0,"RDExpenses":232212000.0,"operatingIncome":-305874000.0,"nonOperatingIncome":1266000.0,"nonOperatingExpenses":2738000.0,"interestExpense":null,"ordinaryProfit":-307346000.0,"extraordinaryGain":6434000.0,"extraordinaryLoss":null,"incomeBeforeTax":-300911000.0,"incomeTaxes":1258000.0,"netIncome":-302169000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-302169000.0,"comprehensiveIncome":-301755000.0,"eps":-20.93,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2020\/5\/14","stockCode":4586,"accountingYear":null,"accountingYearStart":"2020\/1\/1","accountingYearEnd":"2020\/12\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E27208","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":5101,"settlementDate":"2022\/12\/31","submitterName":"株式会社メドレックス","submitterNameEnglish":null,"submitterNameKana":"カブシキガイシャメドレックス","location":"東かがわ市西山４３１番地７","industory":"医薬品","corporateNumber":3470000000000.0},{"edinetCode":"E27208","endDate":"2020\/6\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":2278400.0,"sharesOwendPercent":0.1436,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.893,"cashAndCashEquivalents":1295792000.0,"assets":1811417000.0,"currentAssets":1377642000.0,"fixedAsset":433775000.0,"tangibleFixedAssets":358790000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":74984000.0,"liabilities":146834000.0,"currentLiabilities":119661000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":27173000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":1664582000.0,"capitalStock":1618618000.0,"capital":6934014000.0,"capitalSurplus":6503214000.0,"accumulatedEarnings":-11818611000.0,"treasuryStock":null,"valuationAndConversionAdjustments":-1788000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":15092000.0,"costOfSales":3913000.0,"grossProfit":11179000.0,"sgaExpenses":717332000.0,"salaryAndBenefit":18111000.0,"depreciationAndSGA":1688000.0,"RDExpenses":574709000.0,"operatingIncome":-706153000.0,"nonOperatingIncome":1312000.0,"nonOperatingExpenses":9105000.0,"interestExpense":null,"ordinaryProfit":-713947000.0,"extraordinaryGain":6434000.0,"extraordinaryLoss":null,"incomeBeforeTax":-707512000.0,"incomeTaxes":5998000.0,"netIncome":-713510000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-713510000.0,"comprehensiveIncome":-713287000.0,"eps":-47.11,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":-533162000.0,"depreciationAndCashflowFromOperatingActivities":24794000.0,"cashFlowFromInvestingActivities":-38243000.0,"cashFlowFromFinancialActivities":457900000.0,"changesInCashAndCashEquivalents":-114999000.0,"列1":"q2r","submitDate":"2020\/8\/14","stockCode":4586,"accountingYear":null,"accountingYearStart":"2020\/1\/1","accountingYearEnd":"2020\/12\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E27208","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":5101,"settlementDate":"2022\/12\/31","submitterName":"株式会社メドレックス","submitterNameEnglish":null,"submitterNameKana":"カブシキガイシャメドレックス","location":"東かがわ市西山４３１番地７","industory":"医薬品","corporateNumber":3470000000000.0},{"edinetCode":"E27208","endDate":"2020\/9\/30","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.937,"cashAndCashEquivalents":null,"assets":1875790000.0,"currentAssets":1450657000.0,"fixedAsset":425133000.0,"tangibleFixedAssets":344586000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":80546000.0,"liabilities":64197000.0,"currentLiabilities":36989000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":27207000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":1811593000.0,"capitalStock":1758938000.0,"capital":7138025000.0,"capitalSurplus":6707225000.0,"accumulatedEarnings":-12086312000.0,"treasuryStock":null,"valuationAndConversionAdjustments":-2118000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":15092000.0,"costOfSales":3913000.0,"grossProfit":11179000.0,"sgaExpenses":969424000.0,"salaryAndBenefit":26694000.0,"depreciationAndSGA":2581000.0,"RDExpenses":764769000.0,"operatingIncome":-958245000.0,"nonOperatingIncome":1344000.0,"nonOperatingExpenses":21818000.0,"interestExpense":null,"ordinaryProfit":-978720000.0,"extraordinaryGain":6434000.0,"extraordinaryLoss":null,"incomeBeforeTax":-972285000.0,"incomeTaxes":8925000.0,"netIncome":-981211000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-981211000.0,"comprehensiveIncome":-981318000.0,"eps":-63.06,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2020\/11\/13","stockCode":4586,"accountingYear":null,"accountingYearStart":"2020\/1\/1","accountingYearEnd":"2020\/12\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E27208","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":5101,"settlementDate":"2022\/12\/31","submitterName":"株式会社メドレックス","submitterNameEnglish":null,"submitterNameKana":"カブシキガイシャメドレックス","location":"東かがわ市西山４３１番地７","industory":"医薬品","corporateNumber":3470000000000.0},{"edinetCode":"E27208","endDate":"2020\/12\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":24.0,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":3714290.0,"sharesOwendPercent":0.1911,"outstandingShares":null,"numberOfSubsidiary":1.0,"bps":108.06,"equityRatio":0.914,"cashAndCashEquivalents":1812360000.0,"assets":2297368000.0,"currentAssets":1886875000.0,"fixedAsset":410493000.0,"tangibleFixedAssets":328282000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":82210000.0,"liabilities":149880000.0,"currentLiabilities":122671000.0,"shorTermDept":50000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":27209000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":2147487000.0,"capitalStock":2102713000.0,"capital":7376630000.0,"capitalSurplus":6945830000.0,"accumulatedEarnings":-12219746000.0,"treasuryStock":null,"valuationAndConversionAdjustments":-2606000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":115092000.0,"costOfSales":3913000.0,"grossProfit":111179000.0,"sgaExpenses":1241599000.0,"salaryAndBenefit":35161000.0,"depreciationAndSGA":3475000.0,"RDExpenses":967071000.0,"operatingIncome":-1130420000.0,"nonOperatingIncome":1485000.0,"nonOperatingExpenses":23596000.0,"interestExpense":367000.0,"ordinaryProfit":-1152532000.0,"extraordinaryGain":45964000.0,"extraordinaryLoss":null,"incomeBeforeTax":-1106567000.0,"incomeTaxes":8078000.0,"netIncome":-1114645000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-1114645000.0,"comprehensiveIncome":-1115240000.0,"eps":-68.61,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":-985354000.0,"depreciationAndCashflowFromOperatingActivities":55844000.0,"cashFlowFromInvestingActivities":-5098000.0,"cashFlowFromFinancialActivities":1393651000.0,"changesInCashAndCashEquivalents":401568000.0,"列1":"asr","submitDate":"2021\/3\/29","stockCode":4586,"accountingYear":"第19期（自? 2020年１月１日? 至? 2020年12月31日）","accountingYearStart":"2020\/1\/1","accountingYearEnd":"2020\/12\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E27208","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":5101,"settlementDate":"2022\/12\/31","submitterName":"株式会社メドレックス","submitterNameEnglish":null,"submitterNameKana":"カブシキガイシャメドレックス","location":"東かがわ市西山４３１番地７","industory":"医薬品","corporateNumber":3470000000000.0},{"edinetCode":"E27208","endDate":"2021\/3\/31","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.907,"cashAndCashEquivalents":null,"assets":2080730000.0,"currentAssets":1684251000.0,"fixedAsset":396479000.0,"tangibleFixedAssets":314648000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":81830000.0,"liabilities":132679000.0,"currentLiabilities":105442000.0,"shorTermDept":50000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":27237000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":1948051000.0,"capitalStock":1889652000.0,"capital":7401590000.0,"capitalSurplus":6970790000.0,"accumulatedEarnings":-12482728000.0,"treasuryStock":null,"valuationAndConversionAdjustments":-3286000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":7485000.0,"costOfSales":1943000.0,"grossProfit":5542000.0,"sgaExpenses":267801000.0,"salaryAndBenefit":8775000.0,"depreciationAndSGA":853000.0,"RDExpenses":196329000.0,"operatingIncome":-262258000.0,"nonOperatingIncome":524000.0,"nonOperatingExpenses":2657000.0,"interestExpense":471000.0,"ordinaryProfit":-264391000.0,"extraordinaryGain":2689000.0,"extraordinaryLoss":null,"incomeBeforeTax":-261702000.0,"incomeTaxes":1278000.0,"netIncome":-262981000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-262981000.0,"comprehensiveIncome":-263661000.0,"eps":-13.37,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2021\/5\/14","stockCode":4586,"accountingYear":null,"accountingYearStart":"2021\/1\/1","accountingYearEnd":"2021\/12\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E27208","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":5101,"settlementDate":"2022\/12\/31","submitterName":"株式会社メドレックス","submitterNameEnglish":null,"submitterNameKana":"カブシキガイシャメドレックス","location":"東かがわ市西山４３１番地７","industory":"医薬品","corporateNumber":3470000000000.0},{"edinetCode":"E27208","endDate":"2021\/6\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":3448726.0,"sharesOwendPercent":0.1645,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.717,"cashAndCashEquivalents":2252580000.0,"assets":2690259000.0,"currentAssets":2309077000.0,"fixedAsset":381181000.0,"tangibleFixedAssets":299613000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":81568000.0,"liabilities":700802000.0,"currentLiabilities":673540000.0,"shorTermDept":50000000.0,"currentPortionOfBonds":550000000.0,"currentPortionOfLongTermDebt":null,"fixedLiabilities":27262000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":1989456000.0,"capitalStock":1929869000.0,"capital":7526970000.0,"capitalSurplus":7096170000.0,"accumulatedEarnings":-12693272000.0,"treasuryStock":null,"valuationAndConversionAdjustments":-1102000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":7485000.0,"costOfSales":1943000.0,"grossProfit":5542000.0,"sgaExpenses":477119000.0,"salaryAndBenefit":16668000.0,"depreciationAndSGA":1706000.0,"RDExpenses":331924000.0,"operatingIncome":-471577000.0,"nonOperatingIncome":45000.0,"nonOperatingExpenses":11966000.0,"interestExpense":969000.0,"ordinaryProfit":-483498000.0,"extraordinaryGain":12203000.0,"extraordinaryLoss":null,"incomeBeforeTax":-471295000.0,"incomeTaxes":2230000.0,"netIncome":-473525000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-473525000.0,"comprehensiveIncome":-472020000.0,"eps":-23.94,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":-424174000.0,"depreciationAndCashflowFromOperatingActivities":30121000.0,"cashFlowFromInvestingActivities":-1410000.0,"cashFlowFromFinancialActivities":864330000.0,"changesInCashAndCashEquivalents":440219000.0,"列1":"q2r","submitDate":"2021\/8\/11","stockCode":4586,"accountingYear":null,"accountingYearStart":"2021\/1\/1","accountingYearEnd":"2021\/12\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E27208","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":5101,"settlementDate":"2022\/12\/31","submitterName":"株式会社メドレックス","submitterNameEnglish":null,"submitterNameKana":"カブシキガイシャメドレックス","location":"東かがわ市西山４３１番地７","industory":"医薬品","corporateNumber":3470000000000.0},{"edinetCode":"E27208","endDate":"2021\/9\/30","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.938,"cashAndCashEquivalents":null,"assets":2186826000.0,"currentAssets":1820590000.0,"fixedAsset":366236000.0,"tangibleFixedAssets":284751000.0,"intangibleFixedAssets":null,"investmentAndOtherAssets":81484000.0,"liabilities":73493000.0,"currentLiabilities":46206000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":27287000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":2113332000.0,"capitalStock":2052532000.0,"capital":7690291000.0,"capitalSurplus":7259491000.0,"accumulatedEarnings":-12897250000.0,"treasuryStock":null,"valuationAndConversionAdjustments":-1267000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":8320000.0,"costOfSales":2263000.0,"grossProfit":6056000.0,"sgaExpenses":681365000.0,"salaryAndBenefit":23981000.0,"depreciationAndSGA":2559000.0,"RDExpenses":474136000.0,"operatingIncome":-675308000.0,"nonOperatingIncome":1689000.0,"nonOperatingExpenses":14422000.0,"interestExpense":1473000.0,"ordinaryProfit":-688041000.0,"extraordinaryGain":12331000.0,"extraordinaryLoss":null,"incomeBeforeTax":-675709000.0,"incomeTaxes":1793000.0,"netIncome":-677503000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-677503000.0,"comprehensiveIncome":-676164000.0,"eps":-32.93,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2021\/11\/12","stockCode":4586,"accountingYear":null,"accountingYearStart":"2021\/1\/1","accountingYearEnd":"2021\/12\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E27208","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":5101,"settlementDate":"2022\/12\/31","submitterName":"株式会社メドレックス","submitterNameEnglish":null,"submitterNameKana":"カブシキガイシャメドレックス","location":"東かがわ市西山４３１番地７","industory":"医薬品","corporateNumber":3470000000000.0}]